发明授权
US06083501A Drug for prevention and therapy of diseases caused by fibrinoid
formation or thrombus formation in the lung and model animals of the
diseases
失效
用于预防和治疗由肺中的纤维蛋白形成或血栓形成引起的疾病和疾病的模型动物的药物
- 专利标题： Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases
- 专利标题（中）： 用于预防和治疗由肺中的纤维蛋白形成或血栓形成引起的疾病和疾病的模型动物的药物
-
申请号： US592341申请日： 1996-03-14
-
公开(公告)号： US06083501A公开(公告)日： 2000-07-04
- 发明人: Masayuki Miyata , Reiji Kasukawa , Masanobu Naruto , Nobutaka Ida , Yu-ichiro Sato , Katsuaki Kojima , Nobuo Ida
- 申请人： Masayuki Miyata , Reiji Kasukawa , Masanobu Naruto , Nobutaka Ida , Yu-ichiro Sato , Katsuaki Kojima , Nobuo Ida
- 申请人地址： JPX Tokyo
- 专利权人： Toray Industries, Inc.
- 当前专利权人： Toray Industries, Inc.
- 当前专利权人地址： JPX Tokyo
- 优先权： JPX6-124932 19950607
- 主分类号： A61K38/00
- IPC分类号： A61K38/00 ; A61K49/00 ; A61P7/02 ; C07K16/24 ; A61K39/395 ; A01N37/08 ; C07C59/147 ; C07K16/00
摘要：
A drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation, as well as a model animal of fibrinoid formation or thrombus formation in the lung is disclosed. The drug for preventing and treating diseases caused by fibrinoid formation or thrombus formation in the lung according to the present invention comprises an inhibitor of interleukin 6 as an effective ingredient. The model animal of the diseases caused by fibrinoid formation or thrombus formation in the lung is a rat in which fibrinoid formation or thrombus formation actually occurs by induction with interleukin 6.
公开/授权文献
- US4058601A Method for treating alcoholism 公开/授权日：1977-11-15
信息查询
IPC分类:
